Skip to content

Author

Iván Cheng-Sánchez

We have 2 of 35 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Strategy-based design for the identification of next generation β-lactam antibiotics that evade resistance from Gram-negative pathogens.

INTRODUCTION β-Lactam antibiotics have defined antibacterial chemotherapy for over eight decades and remain indispensable for the treatment of bacterial infections. Despite their clinical success, escalating antimicrobial resistance, particularly among Gram-negative pathogens, continues to impair their efficacy. This c...

Michio Kurosu, Iván Cheng-Sánchez, M. Aboulwafa et al. · 0 citations
Open access Jul 2026

Rationally Engineered, Chemically Stable Tunicamycin Analogues Decouple DPAGT1 Inhibition from Non-Selective Toxicity

Tunicamycin cyclitol analogues are established as a structurally distinct class of selective DPAGT1-targeted anticancer agents and it is demonstrated that stabilization of the glycosidic linkage is an effective strategy for enhancing pharmacological selectivity, improving in vivo performance, and simplifying the synthe...

Katsuhiko Mitachi, A. Sánchez‐Ruiz, D. Mingle et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.